FROZEN SECTION REVEALING THE ABSENCE OF LYMPHATIC TISSUE DURING SENTINEL LYMPH NODE BIOPSY IN ENDOMETRIAL CANCER STAGING.

Author(s):  
Jvan Casarin
Author(s):  
Maria C. Cusimano ◽  
Danielle Vicus ◽  
Katherine Pulman ◽  
Manjula Maganti ◽  
Marcus Q. Bernardini ◽  
...  

2017 ◽  
Vol 72 (8) ◽  
pp. 479-480 ◽  
Author(s):  
Emma C. Rossi ◽  
Lynn D. Kowalski ◽  
Jennifer Scalici ◽  
Leigh Cantrell ◽  
Kevin Schuler ◽  
...  

2018 ◽  
Vol 149 ◽  
pp. 89
Author(s):  
B.L. Manning-Geist ◽  
A.J. Bregar ◽  
W.B. Growdon ◽  
J.A.A. Rauh-Hain ◽  
D.M. Boruta ◽  
...  

2020 ◽  
Vol 23 (1) ◽  
Author(s):  
Linas Andreika ◽  
Margarita Montrimaitė ◽  
Juliana Andreičik

Summary. Endometrial cancer is the most common gynecological cancer in developed countries. Biopsy of the sentinel lymph node can be considered as an alternative to full lymphadenectomy. In order to identify sentinel lymph nodes, a tracer substance is injected into the uterus to visualize the lymphatic tract. Commonly used tracer substances are Technetium-99m (99mTc) colloid, blue dyes, and indocyanine green (ICG). In this review the significance of sentinel lymph node biopsy in endometrial cancer management and the technique of the procedure is discussed.


Sign in / Sign up

Export Citation Format

Share Document